About this trial
This study aims to evaluate the efficacy, safety, and potential mechanisms of prednisolone acetate eye drops for pain management in patients undergoing second-eye surgery for age-related cataracts.
Researchers will compare prednisolone acetate eye drops to sodium hyaluronate eye drops to see if prednisolone acetate eye drops work to relieve intraoperative and postoperative pain during second-eye cataract surgery.
Participants will:
1. Receive prednisolone acetate eye drops or sodium hyaluronate eye drop four drops within 2 hours before cataract surgery 2. Finish cataract surgery and routine postoperative follow-up 3. Pain questionnaire completed after cataract surgery
Eligibility criteria
Qualifiers
Age between 50-80 years old;
A clear diagnosis of age-related cataract, having completed the first eye cataract surgery at our hospital, and planning to have the second eye cataract surgery with the same doctor;
The interval between the two surgeries is ≤30 days;
Capable of cooperating to complete iris optical coherence tomography angiography examination;
Disqualifiers
History of ocular trauma, ocular surgery, uveitis, fundus disease, glaucoma, or recent history of episcleritis, keratitis, severe dry eye, and other ocular surface disease episodes;
Participation in intraocular or systemic medication clinical trials within the past 6 months;
Having an autoimmune disease or currently undergoing immunosuppressive therapy;
Having a psychiatric disorder such as anxiety or depression;
Trial design
Treatments tested in this trial
- Prednisolone acetate eye drop group
- Sodium hyaluronate eye drops